These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19373848)
1. Death and serious illness following influenza vaccination: a multidisciplinary investigation. Rue-Cover A; Iskander J; Lyn S; Burwen DR; Gargiullo P; Shadomy S; Blostein J; Bridges CB; Haber P; Satzger RD; Ball R; Seward JF Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):504-11. PubMed ID: 19373848 [TBL] [Abstract][Full Text] [Related]
2. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511 [TBL] [Abstract][Full Text] [Related]
3. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; Ward BJ; West DJ Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):825-40. PubMed ID: 15386719 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. Hak E; Wei F; Nordin J; Mullooly J; Poblete S; Nichol KL J Infect Dis; 2004 Feb; 189(3):450-8. PubMed ID: 14745702 [TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Souayah N; Nasar A; Suri MF; Qureshi AI J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016 [TBL] [Abstract][Full Text] [Related]
6. Deaths following influenza vaccination--background mortality or causal connection? Kokia ES; Silverman BG; Green M; Kedem H; Guindy M; Shemer J Vaccine; 2007 Dec; 25(51):8557-61. PubMed ID: 18006121 [TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Shapiro Y; Shemer J; Heymann A; Shalev V; Maharshak N; Chodik G; Green MS; Kokia E Isr Med Assoc J; 2003 Oct; 5(10):706-8. PubMed ID: 14719464 [TBL] [Abstract][Full Text] [Related]
8. Monitoring vaccine safety during an influenza pandemic. Iskander J; Haber P; Herrera G Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333 [TBL] [Abstract][Full Text] [Related]
9. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters. Mullooly JP; Crane B; Chun C Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995 [TBL] [Abstract][Full Text] [Related]
10. A cluster of deaths following influenza vaccination, Israel, 2006. Anis E; Leventhal A; Slater PE; Arbeli Y; Sivan Y; Berlovitz Y; Lev B; Israeli A J Public Health Policy; 2010 Sep; 31(3):318-23. PubMed ID: 20805804 [TBL] [Abstract][Full Text] [Related]
11. Community acquired influenza requiring hospitalization: vaccine status is unrelated to morbidity in children with cancer. Kersun LS; Coffin SE; Leckerman KH; Ingram M; Reilly AF Pediatr Blood Cancer; 2010 Jan; 54(1):79-82. PubMed ID: 19743304 [TBL] [Abstract][Full Text] [Related]
12. Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature. McNeil MM; Chiang IS; Wheeling JT; Zhang Y Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):259-74. PubMed ID: 17245803 [TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939 [TBL] [Abstract][Full Text] [Related]
15. [Adverse events following influenza vaccination: reaction to specific reports and the necessity of a central registration system]. Swaan CM; van der Sande MA; Speelman P; Conyn-van Spaendonck MA; Straus SM; Coutinho RA Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2166-9. PubMed ID: 17957995 [TBL] [Abstract][Full Text] [Related]
16. Evaluating adverse events after vaccination in the Medicare population. Burwen DR; La Voie L; Braun MM; Houck P; Ball R Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):753-61. PubMed ID: 17385786 [TBL] [Abstract][Full Text] [Related]
17. [Surveillance of secondary effects of vaccination]. Duclos P Sante; 1994; 4(3):215-20. PubMed ID: 7921691 [TBL] [Abstract][Full Text] [Related]
18. A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine. Ambrozaitis A; Groth N; Bugarini R; Sparacio V; Podda A; Lattanzi M Vaccine; 2009 Oct; 27(43):6022-9. PubMed ID: 19666152 [TBL] [Abstract][Full Text] [Related]
19. Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003. Payne DC; Rose CE; Kerrison J; Aranas A; Duderstadt S; McNeil MM Arch Neurol; 2006 Jun; 63(6):871-5. PubMed ID: 16769869 [TBL] [Abstract][Full Text] [Related]
20. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring. Härmark L; van Hunsel F; Hak E; van Grootheest K Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]